<DOC>
	<DOCNO>NCT01366846</DOCNO>
	<brief_summary>ITN049AD ( LEAP-On ) Study continuation ITN032AD LEAP Study ( NCT00329784 ) . Peanut Allergy , recognize public health concern , common potentially life-threatening food allergy treatment . ITN032AD ( LEAP ) Study evaluate whether early exposure peanut promote tolerance provide protection develop peanut allergy child allergic egg severe eczema . ITN049AD ( LEAP-On ) Study evaluate persistent tolerance peanut assess effect twelve month cessation peanut consumption LEAP Study participant consume peanut avoid peanut previous five year .</brief_summary>
	<brief_title>Persistence Oral Tolerance Peanut</brief_title>
	<detailed_description>This two-sample comparison employ available study participant arm LEAP ( NCT00329784 ) study visit 72 . After obtain informed consent , LEAP participant evaluable peanut allergy age 60 month ( V60 ) enrol study , LEAP-On ( NCT01366846 ) Study . All LEAP-On participant avoid peanut additional 12 month regardless previous allocation LEAP Study consumption arm ( Group A ) LEAP Study avoidance arm ( Group B ) . At V72 , 12 month new intervention , participant skin prick testing ( SPT ) , specific IgE repeat oral challenge peanut determine frequency peanut allergy group . The LEAP Study decision table use determine presence peanut allergy . Briefly , peanut allergy base presence positive oral peanut challenge objective sign allergy . Tolerance establish basis negative oral peanut challenge ( tolerate 5 g peanut protein absence symptom ) . For participant oral challenge oral challenge V72 determinate outcome , follow criterion use determine outcome V72 : - If participant tolerant IgE &gt; 0.1 and/or SPT &gt; 0 mm V60 , participant consider non-evaluable included analysis . - For participant , V60 outcome apply V72 outcome ( last observation carry forward ) . Predictive value peanut-specific IgE and/or SPT use LEAP-On study participant peanut consumption arm LEAP study tolerate peanut despite high IgE and/or SPT .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<mesh_term>Egg Hypersensitivity</mesh_term>
	<criteria>All LEAP Study participant evaluable peanut allergy year 5 LEAP ( ClinicalTrials.gov ID NCT00329784 ) Study criterion . Parent guardian willing provide inform consent . Unable unwilling comply study intervention procedure . Participation food allergy intervention trial .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Peanut</keyword>
</DOC>